Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults. https://t.co/3CcuYa0NA1
RT @Office_j: 【DM発症高リスク例をスクリーニングしても、非スクリーニング群に比べ、死亡、CVイベントともリスクは減少せず:非ランダム化約200万名9.5年 [中央値] 追跡データ解析】 Diabetolgia https://t.co/DdMDPHyWgt…
RT @Office_j: 【DM発症高リスク例をスクリーニングしても、非スクリーニング群に比べ、死亡、CVイベントともリスクは減少せず:非ランダム化約200万名9.5年 [中央値] 追跡データ解析】 Diabetolgia https://t.co/DdMDPHyWgt…
RT @Office_j: 【DM発症高リスク例をスクリーニングしても、非スクリーニング群に比べ、死亡、CVイベントともリスクは減少せず:非ランダム化約200万名9.5年 [中央値] 追跡データ解析】 Diabetolgia https://t.co/DdMDPHyWgt…
【DM発症高リスク例をスクリーニングしても、非スクリーニング群に比べ、死亡、CVイベントともリスクは減少せず:非ランダム化約200万名9.5年 [中央値] 追跡データ解析】 Diabetolgia https://t.co/DdMDPHyWgt 印刷版出来
RT @DiabetologiaJnl: #Diabetes #screening not associated with reduction in mortality or #CVD at the population level @MRC_Epid @AarhusUni h…
#Diabetes #screening not associated with reduction in mortality or #CVD at the population level @MRC_Epid @AarhusUni https://t.co/W4erOxN5uk
[Denmark] screening..for t2d & CV risk factors among all middle-aged adults in DN..not assoc w a reduction in rate of mortality/CV events https://t.co/HDlXTq0FIx
RT @DiabetologiaJnl: #Diabetes #screening not associated with reduction in mortality or #CVD at the population level @MRC_Epid @AarhusUni h…
#Diabetes #screening not associated with reduction in mortality or #CVD at the population level @MRC_Epid @AarhusUni https://t.co/W4erOxvu5K
@parthaskar @felly500 @trishgreenhalgh @JAMAInternalMed >4 Seems to be a dichotomy w/ the @PubMedHealth abstract of trial. C conclusion https://t.co/3ujr9YVJKI. Is this a typo Hilda @hildabast ?
RT @Office_j: 【デンマーク非DM 190万人9.5年 [中央値] 観察振り返り解析:DMスクリーニングで、死亡、CV死のHRは有意減少せず。いずれも、0.99 [95%CI 0.96-1.02]】 Diabetologia https://t.co/TmYFOC…
【デンマーク非DM 190万人9.5年 [中央値] 観察振り返り解析:DMスクリーニングで、死亡、CV死のHRは有意減少せず。いずれも、0.99 [95%CI 0.96-1.02]】 Diabetologia https://t.co/TmYFOCpiHP 印刷版出来
#Diabetes #screening not associated with reduction in mortality or #CVD at the population level @MRC_Epid @AarhusUni https://t.co/W4erOxvu5K
Effect screening #diabetESP cardiovascular risk factors on mortality rate /cardiovascular events controlled trial https://t.co/5HOsE6MeF7 https://t.co/IUCsPw8jrE
RT @DiabetologiaJnl: Mixed results from three studies of T2DM screening https://t.co/8qlNLQ2YVn https://t.co/s7B39HHPn5 https://t.co/3vk…
RT @DiabetologiaJnl: Population-based screening for T2DM – yes or no? https://t.co/8qlNLPLnwN https://t.co/s7B39HZqeD https://t.co/3vk9Kvt…
RT @DiabetologiaJnl: Population-based screening for T2DM – yes or no? https://t.co/8qlNLPLnwN https://t.co/s7B39HZqeD https://t.co/3vk9Kvt…
RT @DiabetologiaJnl: Population-based screening for T2DM – yes or no? https://t.co/8qlNLPLnwN https://t.co/s7B39HZqeD https://t.co/3vk9Kvt…
RT @DiabetologiaJnl: Population-based screening for T2DM – yes or no? https://t.co/8qlNLPLnwN https://t.co/s7B39HZqeD https://t.co/3vk9Kvt…
Population-based screening for T2DM – yes or no? https://t.co/8qlNLPLnwN https://t.co/s7B39HZqeD https://t.co/3vk9Kvts8K #T2D
RT @Kaththomasset: Should we screen for type 2 diabetes? Yes or no? https://t.co/RC8nOsEP56
Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and… https://t.co/gKKutwO0iD
Should we screen for T2DM? https://t.co/8qlNLPLnwN https://t.co/3vk9Kvts8K https://t.co/s7B39HZqeD
RT @DiabetologiaJnl: Mixed results from three studies of T2DM screening https://t.co/8qlNLQ2YVn https://t.co/s7B39HHPn5 https://t.co/3vk…
RT @DiabetologiaJnl: Mixed results from three studies of T2DM screening https://t.co/8qlNLQ2YVn https://t.co/s7B39HHPn5 https://t.co/3vk…
Should we screen for type 2 diabetes? Yes or no? https://t.co/RC8nOsEP56
RT @DiabetologiaJnl: Mixed results from three studies of T2DM screening https://t.co/8qlNLQ2YVn https://t.co/s7B39HHPn5 https://t.co/3vk…
Mixed results from three studies of T2DM screening https://t.co/8qlNLQ2YVn https://t.co/s7B39HHPn5 https://t.co/3vk9KvbRhc @EASDnews #T2D